Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors

Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors

US Patent 10800826 · Granted Oct 13, 2020

Estimated economic value: $388,195,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phthalocyanine dye conjugate compositions2025
PCSK9 antagonist compounds2025
Anti-TIGIT antibodies2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Cyclic polypeptides for PCSK9 inhibition2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Anti-TIGIT antibodies2024
Cyclic polypeptides for PCSK9 inhibition2024
Phosphonate linkers and their use to facilitate cellular retention of compounds2024
Modified relaxin polypeptides and their uses2023
Antibody peptide conjugates that have agonist activity at both the glucagon and 2023
Antibody peptide conjugates that have agonist activity at both the glucagon and 2023